関節内補充療法市場：製品別（5回注射、単回注射、3回注射）、供給源別（動物、非動物）、用途別、最終用途別-2023-2030年の世界予測

関節内補充療法の世界市場は、2023年にCAGR 6.17%で28億3,996万米ドルが予測され、2030年には驚異的な43億2,578万米ドルに達すると予測され、大きく成長すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の関節内補充療法市場を評価するために不可欠です。ビジネス戦略と製品満足度の主要指標を検証することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.関節内補充療法の世界市場規模および予測は？

2.予測期間中、世界の関節内補充療法市場を形成するCOVID-19の阻害要因と影響は？

3.関節内補充療法の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.関節内補充療法の世界市場における競争戦略は？

5.関節内補充療法の世界市場における技術動向と規制の枠組みは？

6.関節内補充療法の世界市場における主要ベンダーの市場シェアは？

7.関節内補充療法の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 変形性関節症に対する非外科的治療のニーズの高まり
    • 食生活の変化に伴う生活習慣病の増加
    • 世界的に高齢者人口と肥満が急増
  • 抑制要因
    • ヒアルロン酸ベースの治療の副作用と高額な費用
  • 機会
    • ヒアルロン酸ベースの治療法の開発における継続的な進歩
    • 膝蓋骨軟骨症における関節内補充療法の役割の拡大
  • 課題
    • 潤滑剤と鎮痛剤の承認および短期間の投与に関する厳格な規制義務
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 関節内補充療法市場：製品別

• ファイブインジェクション
• 単回注入
• スリーインジェクション

第7章 関節内補充療法市場：ソース別

• 動物
• 非動物

第8章 関節内補充療法市場：用途別

• 手の変形性関節症
• 変形性股関節症
• 変形性膝関節症

第9章 関節内補充療法市場：最終用途別

• 病院
• 整形外科クリニック/外来手術センター（ASC）

第10章 南北アメリカの関節内補充療法市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の関節内補充療法市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの関節内補充療法市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第14章 掲載企業一覧

第15章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. VISCOSUPPLEMENTATION MARKET RESEARCH PROCESS
• FIGURE 2. VISCOSUPPLEMENTATION MARKET SIZE, 2022 VS 2030
• FIGURE 3. VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
• FIGURE 6. VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
• FIGURE 7. VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2022 VS 2030 (%)
• FIGURE 8. VISCOSUPPLEMENTATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 9. VISCOSUPPLEMENTATION MARKET DYNAMICS
• FIGURE 10. VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 18. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 19. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. VISCOSUPPLEMENTATION MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. VISCOSUPPLEMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. VISCOSUPPLEMENTATION MARKET SIZE, BY FIVE INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. VISCOSUPPLEMENTATION MARKET SIZE, BY SINGLE INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 7. VISCOSUPPLEMENTATION MARKET SIZE, BY THREE INJECTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 9. VISCOSUPPLEMENTATION MARKET SIZE, BY ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. VISCOSUPPLEMENTATION MARKET SIZE, BY NONANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. VISCOSUPPLEMENTATION MARKET SIZE, BY HAND OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. VISCOSUPPLEMENTATION MARKET SIZE, BY HIP OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. VISCOSUPPLEMENTATION MARKET SIZE, BY KNEE OSTEOARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 16. VISCOSUPPLEMENTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. VISCOSUPPLEMENTATION MARKET SIZE, BY ORTHOPEDIC CLINICS/AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. BRAZIL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 33. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. CANADA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 37. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. MEXICO VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 42. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. UNITED STATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 44. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 45. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 47. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 48. ASIA-PACIFIC VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 49. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 51. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. AUSTRALIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 53. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 55. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 56. CHINA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 57. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 59. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. INDIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 61. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 63. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDONESIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 65. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 67. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. JAPAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 69. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 71. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. MALAYSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 73. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 75. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. PHILIPPINES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 77. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 79. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. SINGAPORE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 81. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 83. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SOUTH KOREA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 85. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 87. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. TAIWAN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 89. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 91. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. THAILAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 93. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 95. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. VIETNAM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 97. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 98. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 100. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. EUROPE, MIDDLE EAST & AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 102. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 104. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. DENMARK VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 106. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 108. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 109. EGYPT VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 110. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 112. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. FINLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 114. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 116. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. FRANCE VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 118. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 120. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. GERMANY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 122. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 124. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. ISRAEL VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 126. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 128. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ITALY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 130. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 132. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. NETHERLANDS VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 134. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 136. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. NIGERIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 138. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 140. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NORWAY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 142. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 144. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. POLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 146. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 148. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. QATAR VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 150. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 152. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. RUSSIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 154. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 156. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. SAUDI ARABIA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 158. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 160. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SOUTH AFRICA VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 162. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 164. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SPAIN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 166. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 168. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SWEDEN VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 170. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 172. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWITZERLAND VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 174. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 176. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. TURKEY VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 178. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 180. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. UNITED ARAB EMIRATES VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 182. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED KINGDOM VISCOSUPPLEMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
• TABLE 186. VISCOSUPPLEMENTATION MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 187. VISCOSUPPLEMENTATION MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 188. VISCOSUPPLEMENTATION MARKET LICENSE & PRICING

The Global Viscosupplementation Market is forecasted to grow significantly, with a projected USD 2,839.96 million in 2023 at a CAGR of 6.17% and expected to reach a staggering USD 4,325.78 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Viscosupplementation Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Viscosupplementation Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Five Injection, Single Injection, and Three Injection. The Five Injection commanded largest market share of 21.93% in 2022, followed by Three Injection.

Based on Source, market is studied across Animal and Nonanimal. The Animal commanded largest market share of 65.85% in 2022, followed by Nonanimal.

Based on Application, market is studied across Hand Osteoarthritis, Hip Osteoarthritis, and Knee Osteoarthritis. The Knee Osteoarthritis commanded largest market share of 49.64% in 2022, followed by Hip Osteoarthritis.

Based on End-use, market is studied across Hospitals and Orthopedic Clinics/Ambulatory Surgical Centers (ASCs). The Hospitals commanded largest market share of 58.71% in 2022, followed by Orthopedic Clinics/Ambulatory Surgical Centers (ASCs).

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 41.86% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Viscosupplementation Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Viscosupplementation Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Viscosupplementation Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Viscosupplementation Market?

4. What is the competitive strategic window for opportunities in the Global Viscosupplementation Market?

5. What are the technology trends and regulatory frameworks in the Global Viscosupplementation Market?

6. What is the market share of the leading vendors in the Global Viscosupplementation Market?

7. What modes and strategic moves are considered suitable for entering the Global Viscosupplementation Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Viscosupplementation Market, by Product, 2022 vs 2030
• 4.3. Viscosupplementation Market, by Source, 2022 vs 2030
• 4.4. Viscosupplementation Market, by Application, 2022 vs 2030
• 4.5. Viscosupplementation Market, by End-use, 2022 vs 2030
• 4.6. Viscosupplementation Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing Need for Non-Surgical Treatment for Osteoarthritis
    • 5.1.1.2. Rising Occurrence of Lifestyle-Induced Disorders with Changing Eating Habits
    • 5.1.1.3. Surge in Geriatric Population and Obesity Globally
  • 5.1.2. Restraints
    • 5.1.2.1. Side Effects and High Cost of The Hyaluronic Acid-Based Treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing Advancements in the Development of Hyaluronic Acid-Based Therapies
    • 5.1.3.2. Extending Role of Viscosupplementation in Patellar Chondropathy
  • 5.1.4. Challenges
    • 5.1.4.1. Strict Regulatory Mandates for Approval and Short Duration of Lubrication and Pain Relief
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Viscosupplementation Market, by Product

• 6.1. Introduction
• 6.2. Five Injection
• 6.3. Single Injection
• 6.4. Three Injection

7. Viscosupplementation Market, by Source

• 7.1. Introduction
• 7.2. Animal
• 7.3. Nonanimal

8. Viscosupplementation Market, by Application

• 8.1. Introduction
• 8.2. Hand Osteoarthritis
• 8.3. Hip Osteoarthritis
• 8.4. Knee Osteoarthritis

9. Viscosupplementation Market, by End-use

• 9.1. Introduction
• 9.2. Hospitals
• 9.3. Orthopedic Clinics/Ambulatory Surgical Centers (ASCs)

10. Americas Viscosupplementation Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Viscosupplementation Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Viscosupplementation Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. FPNV Positioning Matrix
• 13.2. Market Share Analysis, By Key Player
• 13.3. Competitive Scenario Analysis, By Key Player

14. List of Company Mentioned

15. Appendix

• 15.1. Discussion Guide
• 15.2. License & Pricing